Cellular Dysfunction in Exfoliation Glaucoma
Cellular Dysfunction in Exfoliation Glaucoma
批准号:
9980044
负责人:
AUDREY M BERNSTEIN
金额:
$42.68万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2024-05-31
关键词:
AffectAgeAge related macular degenerationAgingAlzheimer&aposs DiseaseAmino Acid SequenceAmino AcidsAnteriorAutophagocytosisCell LineCellsCellular Stress ResponseCellular biologyChimera organismChronicCiliary BodyCodeComplexCoupledDangerousnessDataDeacetylaseDefectDependenceDepositionDevelopmentDiseaseElastic FiberEndoplasmic Reticulum Degradation PathwayEnzymesEthnic OriginExfoliation SyndromeExperimental ModelsExtracellular MatrixExtracellular ProteinEyeFibroblastsFunctional disorderGenerationsGeneticGenomicsGlaucomaHDAC6 geneHealthHealth StatusHumanHuntington DiseaseImpairmentIrisLinkLiquid substanceMediatingMicrotubulesMitochondriaMolecularMolecular ChaperonesMorbidity - disease rateNeurodegenerative DisordersOpen-Angle GlaucomaParkinson DiseasePathologyPathway interactionsPatientsPopulationPositioning AttributePrimary Open Angle GlaucomaProcessProtein Export PathwayProtein-Lysine 6-OxidaseProteinsPublishingQuality ControlRiskRoleSkinSourceStretchingStructureSurfaceSystemTestingTissuesTrabecular meshwork structureTrabeculectomyTropoelastinUbiquitinVariantage relatedcell immortalizationcrosslinkexperimental studyhigh riskimprovedin silicolensmisfolded proteinmulticatalytic endopeptidase complexoverexpressionpolypeptidepreservationprotein aggregationproteostasisresponsesulfated glycoprotein 2
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract: Cellular Dysfunction in Exfoliation Glaucoma Exfoliation syndrome
(XFS) is an age-related disease involving the deposition of aggregated fibrillar material (XFM) in
extracellular matrices. Its main morbidity is in the eye, where XFM forms on the surface of
anterior segment tissues. XFM causes exfoliation glaucoma (XFG), a rapidly progressing disease
associated with approximately 1/3 of open-angle glaucoma (POAG) cases worldwide. XFG
demonstrates a sharp age-dependence in similarity to the many age-related diseases qualified
as aggregopathies. LOXL1, a matrix cross-linking enzyme that catalyzes the crosslinking of
tropoelastin for the synthesis of elastic fibers and a major component of XFM, has been linked to XFG
by Genomics Wide Association Studies, however, it is still unclear how LOXL1 protein
contributes to disease pathology.Progress in understanding the cellular basis for XFS/G has been
slowed by a lack of experimental models. Working with primary human tenon fibroblasts (TF)
derived from trabeculectomies of XFG patients and controls (age-matched POAG patients and No-
Glaucoma patients), we recently found that, XFG-TFs display many of the functional features
observed in cells from other age-related aggregopathies such as Parkinson's, Alzheimer's, and
AMD including defects in lysosomal positioning, autophagy, microtubule organization and function,
and mitochondrial health status. Linking LOXL1 to the development of XFG, we have found that
XFG-TF a) display increased LOXL1 export by a mechanism aimed at neutralizing misfolded
nascent polypeptides; b) process LOXL1 through autophagy indicating the presence of
misfolded or denatured units of this protein; c) accumulate intracellular protein aggregates with
higher endogenous expression; and d) overexpress clusterin an aggregate-responsive chaperone-
like protein. Finally, an in silico examination of LOXL1 secondary structure indicated that LOXL1
protein has elemental structures within the N-terminus that are predicted to confer an increased
aggregation propensity. Furthermore, experiments of LOXL1 whole protein or with deletions shows
that indeed LOXL1 has high aggregation propensity and that the loci of this propensity reside
within specific stretches of the N-terminus. Accordingly, we seek to answer fundamental
questions on the factors that underpin XFG pathology. We propose, SpA1) to study the molecular
machinery leading to the defects in microtubule function; SpA2) to investigate cellular stress
responses, and the connection between LOXL1 export and misfolded protein machinery, and SpA3)
to identify the minimal amino acid sequences and structural features of the LOXL1 sequence that
mediate its aggregation propensity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Self-Delivery siRNA for Promoting Regenerative Healing in the Eye
-
批准号:10664929
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
A Self-Delivery siRNA for Promoting Regenerative Healing in the Eye
-
批准号:10406147
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Cellular Dysfunction in Exfoliation Glaucoma
-
批准号:10663210
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2020
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Cellular Dysfunction in Exfoliation Glaucoma
-
批准号:10160908
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2020
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Cellular Dysfunction in Exfoliation Glaucoma
-
批准号:10413111
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2020
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
THE UBIQUITIN PATHWAY IN CORNEAL SCARRING
-
批准号:9482016
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2017
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
THE UBIQUITIN PATHWAY IN CORNEAL SCARRING
-
批准号:10581233
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2015
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7238558
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7434324
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7015385
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7844833
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7626280
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7922944
-
项目类别:
-
资助金额:$33.85万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
THE UPA PATHWAY IN CORNEAL STROMA WOUND HEALING
-
批准号:6518392
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2002
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
THE UPA PATHWAY IN CORNEAL STROMA WOUND HEALING
-
批准号:6397748
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2001
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
THE UPA PATHWAY IN CORNEAL STROMA WOUND HEALING
-
批准号:6136366
-
项目类别:
-
资助金额:$3.09万
-
财政年份:2000
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: